Another example is the clinical trial #NCT01865617, where repeated infusions of the same CD19 CAR-T product were performed in patients with chronic lymphocytic leukemia, NHL, or acute lymphoblastic leukemia that have come back or have not responded to previous treatment. The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.